Minimal Oxygen Supplementation Recommended for Most Inpatients
|
By HospiMedica International staff writers Posted on 13 Nov 2018 |
A new guidance statement reports that supplemental oxygen is not always indicated for acutely ill patients, and may contribute to higher mortality.
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
Latest Critical Care News
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
- New Therapeutic Approach Marks Breakthrough in Pediatric Heart Disease
- AI Model Accurately Identifies Prediabetics Using Only ECG Data
- Injectable Disease-Fighting Nanorobots to Improve Precision Cancer Therapy
- Web-Based Tool Enables Early Detection and Prevention of Chronic Kidney Disease
- Tiny Sensor to Transform Head Injury Detection
- Bacterial Behavior Breakthrough to Improve Infection Prevention in Biomedical Devices
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







